Tilray Brands (TLRY) Equity Income (2019 - 2020)

Tilray Brands (TLRY) reported Equity Income of -$1.7 million for Q1 2020, up 34.46% quarter-over-quarter from -$2.7 million in Q4 2019.

Tilray Brands (TLRY) Equity Income (2019 - 2020) Analysis & Trends

Tilray Brands has reported Equity Income for 2 years, with the latest figure at -$1.7 million in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Income (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-1.00 Mn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	-
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	25.30 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	-
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	-9.68 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	14.91 Mn
10	Tilray Brands	-	-	54.95 Mn	-

Download Data